Search

everythinglearnresearchcommunity

for

Search:↓

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

5α-Reductase inhibitors can negatively impact sexual function.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

IsoPSA test works accurately even if patients take certain prostate medications.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Erectile dysfunction in young men is caused by both mental and physical factors and needs a personalized treatment approach.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.